BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20672849)

  • 1. Synthesis, structure determination, and biological evaluation of destruxin E.
    Yoshida M; Takeuchi H; Ishida Y; Yashiroda Y; Yoshida M; Takagi M; Shin-ya K; Doi T
    Org Lett; 2010 Sep; 12(17):3792-5. PubMed ID: 20672849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Total Synthesis of Biologically Active Natural Products toward Elucidation of the Mode of Action].
    Yoshida M
    Yakugaku Zasshi; 2015; 135(10):1099-108. PubMed ID: 26423864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scalable solution-phase synthesis of the biologically active cyclodepsipeptide destruxin E, a potent negative regulator of osteoclast morphology.
    Yoshida M; Sato H; Ishida Y; Nakagawa H; Doi T
    J Org Chem; 2014 Jan; 79(1):296-306. PubMed ID: 24251640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-Phase Combinatorial Synthesis and Biological Evaluation of Destruxin E Analogues.
    Yoshida M; Ishida Y; Adachi K; Murase H; Nakagawa H; Doi T
    Chemistry; 2015 Dec; 21(50):18417-30. PubMed ID: 26531322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial Solid-Phase Synthesis and Biological Evaluation of Cyclodepsipeptide Destruxin B as a Negative Regulator for Osteoclast Morphology.
    Sato H; Yoshida M; Murase H; Nakagawa H; Doi T
    ACS Comb Sci; 2016 Sep; 18(9):590-5. PubMed ID: 27490097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae.
    Vázquez MJ; Albarrán MI; Espada A; Rivera-Sagredo A; Díez E; Hueso-Rodríguez JA
    Chem Biodivers; 2005 Jan; 2(1):123-30. PubMed ID: 17191925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial Synthesis and Biological Evaluation of Destruxins.
    Yoshida M
    Chem Pharm Bull (Tokyo); 2019; 67(10):1023-1029. PubMed ID: 31582623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis and assignment of the side chain stereochemistry of LI-F04a: an antimicrobial cyclic depsipeptide.
    Cochrane JR; McErlean CS; Jolliffe KA
    Org Lett; 2010 Aug; 12(15):3394-7. PubMed ID: 20608662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase.
    Muroi M; Shiragami N; Takatsuki A
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1358-65. PubMed ID: 7802670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insecticidal activity of destruxin, a mycotoxin from Metarhizium anisopliae (Hypocreales), against Spodoptera litura (Lepidoptera: Noctuidae) larval stages.
    Sowjanya Sree K; Padmaja V; Murthy YL
    Pest Manag Sci; 2008 Feb; 64(2):119-25. PubMed ID: 17935266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of a beauveriolide analogue library.
    Nagai K; Doi T; Sekiguchi T; Namatame I; Sunazuka T; Tomoda H; Omura S; Takahashi T
    J Comb Chem; 2006; 8(1):103-9. PubMed ID: 16398560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
    Tomoda H; Doi T
    Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic studies for destruxins and biological evaluation for osteoclast-like multinucleated cells: a review.
    Yoshida M; Nakagawa H; Doi T
    J Antibiot (Tokyo); 2022 Aug; 75(8):420-431. PubMed ID: 35821085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New destruxins from the marine-derived fungus Beauveria felina.
    Lira SP; Vita-Marques AM; Seleghim MH; Bugni TS; LaBarbera DV; Sette LD; Sponchiado SR; Ireland CM; Berlinck RG
    J Antibiot (Tokyo); 2006 Sep; 59(9):553-63. PubMed ID: 17136888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Lanthanide(III) Triflate Mediated Macrolactonization/Solid-Phase Synthesis Approach for Depsipeptide Synthesis.
    Goodreid JD; dos Santos Eda S; Batey RA
    Org Lett; 2015 May; 17(9):2182-5. PubMed ID: 25866888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis and biological evaluation of halipeptins A and D and analogues.
    Nicolaou KC; Lizos DE; Kim DW; Schlawe D; de Noronha RG; Longbottom DA; Rodriquez M; Bucci M; Cirino G
    J Am Chem Soc; 2006 Apr; 128(13):4460-70. PubMed ID: 16569024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective total synthesis of +-jasplakinolide.
    Ghosh AK; Moon DK
    Org Lett; 2007 Jun; 9(12):2425-7. PubMed ID: 17488037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and assignment of stereochemistry of the antibacterial cyclic peptide xenematide.
    Hung KY; Harris PW; Heapy AM; Brimble MA
    Org Biomol Chem; 2011 Jan; 9(1):236-42. PubMed ID: 20949214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase total synthesis of (-)-apratoxin A and its analogues and their biological evaluation.
    Doi T; Numajiri Y; Takahashi T; Takagi M; Shin-ya K
    Chem Asian J; 2011 Jan; 6(1):180-8. PubMed ID: 21080404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemical determination of Archazolid A and B, highly potent vacuolar-type ATPase inhibitors from the Myxobacterium Archangium gephyra.
    Hassfeld J; Farès C; Steinmetz H; Carlomagno T; Menche D
    Org Lett; 2006 Oct; 8(21):4751-4. PubMed ID: 17020294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.